| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8615153 | Clinical Lymphoma Myeloma and Leukemia | 2018 | 26 Pages |
Abstract
The combination of bortezomib and vorinostat is safe and has modest activity in MCL and limited activity in DLBCL.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Victor Yazbeck, Danielle Shafer, Edward B. Perkins, Domenico Coppola, Lubomir Sokol, Kristy L. Richards, Thomas Shea, Jia Ruan, Samir Parekh, Roger Strair, Christopher Flowers, David Morgan, Maciej Kmieciak, Prithviraj Bose, Amy Kimball,